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Abstract 
Individual variation in the attribution of motivational salience to reward-related cues is 
believed to underlie addiction vulnerability. Pavlovian conditioned approach measures individual 
variation in motivational salience by identifying rats that are attracted to and motivated by 
reward cues (sign-trackers) or motivationally fixed on the reward itself (goal-trackers). 
Previously, it has been demonstrated that sign-trackers are more vulnerable to addiction-like 
behavior. Moreover, sign-trackers release more dopamine in the nucleus accumbens than goal-
trackers in response to reward-related cues, and sign- but not goal-tracking behavior is 
dopamine-dependent. In the present study, we investigated whether the ventral hippocampus, a 
potent driver of dopaminergic activity in the nucleus accumbens, modulates the acquisition and 
expression of Pavlovian conditioned approach behavior. In Experiment 1, lesions of the ventral, 
but not dorsal or total hippocampus, decreased sign-tracking behavior. In Experiment 2, lesions 
of the ventral hippocampus did not affect the expression of sign- or goal-tracking behaviors nor 
conditioned reinforcement. In addition, temporary inactivation of the ventral subiculum, the main 
output pathway of the ventral hippocampus, did not affect the expression of sign- or goal-
tracking behaviors. High-pressure liquid chromatography of nucleus accumbens tissue punches 
revealed that ventral hippocampal lesions decreased levels of homovanillic acid and the 
homovanillic acid/dopamine ratio (a marker of dopamine release and metabolism) in only sign-
trackers, and decreased accumbal norepinephrine levels in both sign- and goal-trackers. These 
results suggest that the ventral hippocampus is important for the acquisition but not expression of 




It is important to understand why some individuals can try potentially addictive drugs 
without developing addiction, while others try the same drug and are quickly rendered incapable 
of controlling their urges to repeat the experience. Individual variation in the incentive-
motivational salience of reward-related cues is believed to contribute to this individual 
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vulnerability to addiction (Flagel et al., 2009). Incentive-motivational salience is typically 
measured using a Pavlovian conditioned approach (PCA) procedure, during which a conditioned 
stimulus (CS; e.g., a lever) response-independently predicts the delivery of an unconditioned 
stimulus (US; e.g., a food pellet). During training, three behavioral phenotypes may emerge: 
sign-trackers (STs), which express primarily CS-directed conditioned responses (CRs), goal-
trackers (GTs), which develop more US-directed CRs, and intermediate responders (IRs), which 
display both CRs. STs are more susceptible to cue-related, addiction-like behaviors than GTs or 
IRs, exhibiting more cue-induced reinstatement of drug-seeking (Saunders and Robinson, 2010; 
Yager et al., 2015) and even seeking drug cues despite adverse consequences (Saunders et al., 
2013).  
Understanding the brain regions that are activated during sign-tracking behavior is 
critical in determining the biological basis of individual variation in incentive-motivational 
salience and drug vulnerability. Previously, it has been demonstrated that food and drug cues 
activate an amygdalo-striatal-thalamic circuit in STs (Flagel et al., 2011a; Yager et al., 2015), 
and lesion studies have confirmed the importance of regions within this circuit (e.g., the nucleus 
accumbens [NAc], basolateral amygdala, and paraventricular nucleus of the thalamus) in the 
acquisition of sign-tracking behavior (Chang et al., 2012; Haight et al., 2015). Other regions with 
important connections to this circuit have been implicated in sign-tracking behavior as well, such 
as the hippocampus (HPC) (Ito et al., 2005), though little is known regarding how subregions of 
this heterogeneous structure individually regulate sign-tracking behavior. 
The hippocampus can be broadly divided into dorsal and ventral regions, which have 
unique connectivity and functions (Fanselow and Dong, 2010). For example, efferents from the 
ventral HPC (vHPC), but not dorsal HPC (dHPC), are potent drivers of dopaminergic activity in 
the NAc, and lesions of the vHPC, but not dHPC, decrease dopamine (DA) levels in the NAc 
(Lipska et al., 1992; Lipska et al., 1991). Moreover, stimulation of the ventral subiculum 
(vSUB), the main output structure of the HPC, increases DA release in the NAc (Blaha et al., 
1997; Taepavarapruk et al., 2000). Because STs release more DA in the NAc than GTs in 
response to reward-related cues, and sign-tracking, but not goal-tracking, behavior is DA-
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dependent (Flagel et al., 2011b; Saunders and Robinson, 2012), it is possible that increased 
ventral hippocampal activity regulates NAc DA in STs, thereby enhancing the incentive-
motivational value of reward-related cues. A reduction of activity in the vHPC would therefore 
be expected to decrease dopaminergic activity in response to reward-related cues and decrease 
sign-tracking behavior.  
 The present study aimed to determine how the HPC and its subregions contribute to the 
acquisition and expression of PCA behavior. We hypothesized that lesions of the vHPC, but not 
dHPC, would decrease sign-tracking behavior during the acquisition and expression of PCA 
behavior. In Experiment 1, rats received sham surgery or lesions of the vHPC, dHPC, or total 
HPC, before undergoing five daily sessions of PCA training. Based on our results from 
Experiment 1, in Experiment 2, rats underwent seven daily sessions of PCA training, followed 
by sham surgery or vHPC lesions, then tested for the expression of PCA behavior and 
conditioned reinforcement. Rats undergoing sham surgeries were implanted with cannulas 
targeting the vSUB, allowing us to temporarily inactivate and further probe the importance of the 
vHPC during the expression of PCA behavior. Following behavioral testing, tissue punches of 
the NAc were analyzed for monoamine and metabolite concentrations of DA as well as 




Adult male Sprague Dawley rats (275-300g) were purchased from Harlan Laboratories 
and Charles River Laboratories to increase phenotypic diversity (Fitzpatrick et al., 2013). Rats 
were maintained on a 12:12-hr light/dark cycle, and food and water were available ad libitum for 
the duration of experimentation. Rats were acclimatized to the housing colony for two days prior 
to handling. All procedures were approved by the University Committee on the Use and Care of 
Animals (University of Michigan; Ann Arbor, MI).  
 
Drugs 
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 N-methyl-D-aspartate (NMDA; #M3262; Sigma-Aldrich, Inc.; St. Louis, MO), lidocaine 
hydrochloride (#L5647; Sigma-Aldrich, Inc.), and Pontamine Sky Blue (PSB; also known as 
Chicago Sky Blue 6B; #C8679); Sigma-Aldrich, Inc.) were used. NMDA was dissolved in sterile 
saline to make a 0.09 M solution (pH = 7.34-7.36). Lidocaine hydrochloride was dissolved in 
sterile saline to make a 20% solution (200 mg/mL; pH = 5.0), as previously described (Kantak et 
al., 2002). Sterile saline was used as the vehicle control.  
 
Pavlovian Conditioned Approach: Apparatus 
Modular conditioning chambers (24.1 cm width × 20.5 cm depth x 29.2 cm height; MED 
Associates, Inc.; St. Albans, VT) were used for Pavlovian conditioning. Each chamber was 
located in a sound-attenuating cabinet equipped with a ventilation fan to provide ambient white 
noise. Each chamber was equipped with a pellet magazine, an illuminated, retractable lever 
(counterbalanced on the left or right of the pellet magazine), and a red house light on the wall 
opposite of the pellet magazine. When inserted into the chamber, the retractable lever was 
illuminated by an LED light within the lever housing. A pellet dispenser delivered banana-
flavored food pellets into the pellet magazine. An infrared sensor inside the pellet magazine 
measured head entries into the pellet magazine.  
 
Pavlovian Conditioned Approach: Procedure 
For two days prior to pretraining, rats were familiarized with banana-flavored food 
pellets (45mg; Bioserv; Frenchtown, NJ) in their home cages. On the third day, rats were placed 
into the chambers and underwent one pretraining session during which the red house light 
remained on but the lever was retracted. Fifty food pellets were delivered on a variable time 
(VT) 30-s schedule (i.e., one food pellet was delivered on average every 30 s, but actual delivery 
varied between 0-60 s). All rats consumed all the food pellets by the end of the pretraining 
session. Each trial during a PCA training session consisted of extension of the illuminated lever 
(the CS) into the chamber for 8 s on a VT 90-s schedule (i.e., one food pellet was delivered on 
average every 90 s, but actual delivery varied between 30-150 s). Retraction of the lever was 
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immediately followed by the response-independent delivery of one food pellet (the US) into the 
pellet magazine. Each test session consisted of 25 trials of CS-US pairings, resulting in a total 
session length of approximately 40 min. Each rat consumed all the food pellets that were 
delivered. 
 
Conditioned Reinforcement: Procedure 
For testing of conditioned reinforcement in Experiment 2, which lasted 40 min, each 
chamber was equipped with two nose-poke ports adjacent to a lever located in the center of the 
front wall of the operant chamber. Nose pokes into the active nose-poke port resulted in 
presentation of the lever-CS for 2 s on a fixed-ratio 1 (FR1) schedule, whereas nose pokes in 
inactive nose-poke port did not result in presentation of the lever-CS.  
 
Surgery 
 For all surgical procedures, rats were administered carprofen (2 mg/kg; s.c.) for 
analgesia, anesthetized using a ketamine (90 mg/kg; i.p.) and xylazine (10 mg/kg; i.p.) solution, 
and placed in a stereotaxic frame (David Kopf Instruments; Tujunga, CA). For excitotoxic 
lesions, injectors (33-gauge; Plastics One, Inc.; Roanoke, VA), connected via PE-20 tubing to 
microsyringes (1 µL; Hamilton Company; Reno, NV) in a pump controller (Harvard Instruments; 
Holliston, MA) were lowered into the HPC. NMDA (0.09 M) was infused bilaterally. For dHPC 
infusions, 0.4 µL was infused at a rate of 0.4 µL/min per infusion site, and infusion cannulas 
were left in place for an additional 4 min before removal. For vHPC infusions, 0.2 µL was 
infused at a rate of 0.2 µL/min per infusion site, and infusion cannulas were left in place for an 
additional 2 min before removal. In Experiment 1, lesions were targeted at the dHPC (two sites; 
anterior-posterior [AP]: -2.8 mm, medial-lateral [ML]: ±1.6 mm, dorsal-ventral [DV]: -3.0 mm; 
AP: -4.2 mm, ML: ±2.6 mm, DV: -3.0 mm), vHPC (four sites: AP: -4.8 mm, ML: ±4.8 mm, DV: 
-6.0 mm; AP: -5.3 mm, ML: ±4.6 mm, DV: -4.2 mm; AP: -5.3 mm, ML: ±4.6 mm, DV: -6.0 
mm; AP: -5.8 mm, ML: ±4.6 mm, DV: -4.2 mm), or total HPC (a combination of the two 
previously described lesions for a total of six sites). AP coordinates were measured from bregma, 
Page 6 of 29
John Wiley & Sons
Hippocampus










 Fitzpatrick 7 
 
DV coordinates were measured from dura, and all coordinates were referenced to Paxinos and 
Watson (2007). In Experiment 1, surgical controls received incisions and burr holes on the skull 
over the HPC, but no infusions were performed. In Experiment 2, surgical controls were 
implanted bilaterally with guide cannulas (26-gauge, cut 7 mm below the pedestal; Plastics One, 
Inc.) targeted at the vSUB (AP: -5.6 mm, ML: ±4.6 mm, DV: -5.8 mm). Injection cannulas that 
would later be inserted into these guide cannulas were 8 mm long, overhanging 1 mm past the 
guide cannula tip. Two jeweler’s screws were secured both anterior and posterior to the burr 
holes, and dental acrylic (Fastray™; Harry J. Bosworth Company; Skokie, IL) was applied 
around the guide cannulas and screws to form a head stage. Dummy cannulas (8 mm, 1 mm 
overhang; Plastics One, Inc.) were inserted into the guide cannulas and removed only during 
testing. Following all surgeries, rats recovered for seven days prior to behavioral testing with 
food and water available ad libitum.  
 
Experiment 1: Procedure 
 Rats underwent pre-conditioning hippocampal lesions (sham, dHPC, vHPC, or total 
HPC) and, following the surgical recovery period, five daily PCA training session to determine 
the effect of hippocampal lesions on the acquisition of PCA behavior. Following the last 
behavioral session, rats were transcardially perfused with a 4% paraformaldehyde solution (PFA; 
in 0.1 M phosphate-buffered saline; pH = 7.34-7.36). Brains were removed, immediately post-
fixed in 4% PFA for one hour, and transferred to a 20% sucrose solution until saturated. Next, 
tissues were sectioned on a cryostat (35 µM; Leica CM1850; Leica Microsystems, Inc.; Buffalo 
Grove, IL), stained with Cresyl Violet (#C5042; Sigma-Aldrich, Inc.), and used for histological 
verification of lesions. Unilateral lesions were excluded from analysis (vHPC, n = 2; dHPC, n = 
4, total HPC, n = 2).  
 
Experiment 2: Procedure 
 Rats underwent seven daily PCA training sessions before hippocampal lesions (sham and 
vHPC). In this experiment, surgical controls were implanted with bilateral cannulas targeted at 
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the vSUB. Following the seven-day surgical recovery period, rats underwent an additional seven 
daily PCA training sessions to determine the effect of post-conditioning lesions on the 
expression of PCA behavior. Twenty-four hours later, rats underwent two more daily PCA 
training sessions during which surgical controls received bilateral infusions (0.5 µL/side) of a 
20% lidocaine solution (100 µg/side; in sterile saline) or vehicle at an infusion rate of 0.5 µL/min 
for 1 min in a counter-balanced manner (i.e., rats received lidocaine or saline during each session 
in a counter-balanced manner). For statistical analysis and graphical presentation, both sessions 
were collapsed into vehicle and lidocaine groups. Infusion cannulas were left in place for an 
additional minute to allow diffusion, and rats immediately underwent testing. Lesion rats also 
underwent two PCA training sessions to ensure that all subjects received equal amounts of PCA 
training. Twenty-four hours later, all rats underwent a test for conditioned reinforcement. Five 
days after the conditioned reinforcement test, sham rats received bilateral infusions (0.5 µL/side) 
of a 2% PSB solution at a flow rate of 0.5 µL/min to dye and visualize infusion sites in the 
vSUB. Infusion cannulas were left in place for an additional minute to allow diffusion. Next, all 
rats were rapidly decapitated and brains were removed and placed into an ice-cold adult rat brain 
matrix. A 1-mm thick tissue section including the NAc (AP: +1.2 mm) was biopsied using 2-mm 
diameter tissue biopsy punches. Whole brains posterior to this section were kept for histological 
verification of lesions and cannula placements. All tissue was immediately flash-frozen in 
isopentane (Sigma Aldrich, Inc.) over dry ice. Tissue punches were later processed to quantify 
levels of the following monoamines and their metabolites: DA, 3,4-dihydrophenylacetic acid 
(DOPAC), homovanillic acid (HVA), 3-methoxytryamine (3-MT), NE, 5-HT, and 5-
hydroxyindoleacetic acid (5-HIAA). Tissue sections were stained with Cresyl Violet (Sigma-
Aldrich, Inc.) and used for histological verification. For lesions, unilateral lesions were excluded 
from further analysis (ST, n = 2). For cannula placement, subjects with an absence of cannula 
tracks and dye were kept for statistical comparison between lesion and sham control; however, 
they were excluded from further analysis for testing of temporary inactivation of the vSUB (GT, 
n = 1; ST, n = 2). 
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High-pressure liquid chromatography (HPLC) 
Frozen tissue samples were weighed and sonically disrupted in 100 µL 0.2N HCLO4. 
Samples were then centrifuged at 4°C at 12,100 g for 10 min. A 50 µL aliquot of supernatant 
was removed and monoamine analysis was performed utilizing a Dionex Ultimate 3000 UHPLS 
system (Thermo Fisher Scientific, Inc.; Waltham, MA). At a flow rate of 0.6 mL/min, 10 µL of 
each sample was injected with an auto-sampler maintained at 4°C and with a 100 µL sample 
loop onto a C18-RP (2-µL diameter) column maintained at 25°C. Test Mobile Phase (Thermo 
Fisher Scientific, Inc.) containing acetonitrile, phosphate buffer, and an ion-pairing reagent was 
used. Coulometric detection was achieved with an ultra-analytical dual electrode cell (Thermo 
Fisher Scientific, Inc.) set at -175 mV (reference electrode) and 300 mV (working electrode). 
Gain settings for both electrodes were set to 100 µA. A guard cell set to 350 mV and guard 
column (2.1/3.0 mm ID; Thermo Fisher Scientific, Inc.) were also used. Monoamine and 
metabolite levels were quantified by comparison to external standards (Sigma-Aldrich, Inc.) ran 
in sequence with tissue samples and corrected for tissue weight. The order of sample analysis 
within the run was randomized. Chromatograms were obtained and analyzed using Chromeleon 
7 Chromatography Data System software (Dionex Corp.; Sunnyvale, CA) with peak heights 
being the output measure. The detection threshold was set at 5 nA, and samples with peak 
heights lower than 5 nA were excluded from analysis. Monoamine and metabolite levels (DA, 
DOPAC, HVA, 3-MT, NE, 5-HT and 5-HIAA) were expressed as absolute tissue values (ng 
neurochemical / mg wet tissue weight; ng/mg). 
 
Statistical Analysis 
PCA behavior was scored using an index that incorporates the number, latency, and 
probability of lever presses (sign-tracking CR) and magazine entries (goal-tracking CR) during 
CS presentations within a session (Meyer et al., 2012). Briefly, we averaged together the 
response bias (i.e., [number of lever presses – number of magazine entries] / [lever presses + 
magazine entries]), latency bias (i.e., [magazine entry latency – lever press latency]/8), and 
probability difference (i.e., lever press probability – magazine entry probability). The PCA index 
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scores behavior from +1.0 (absolute sign-tracking) to -1.0 (absolute goal-tracking), with 0 
representing no bias. When applicable, the average PCA index scores of Sessions 6 and 7 were 
used to classify rats as STs (score ≥ 0.5), GTs (score ≤ -0.5), and IRs (-0.5 < score < 0.5). In 
Experiment 2, IRs were excluded from further experimentation and statistical analysis. For 
conditioned reinforcement, active – inactive nose-poke port responses were quantified and 
compared between groups. 
SPSS (Version 22; IBM, Inc.) was used for all statistical analyses. For all linear mixed 
models, the covariance structure was selected based upon Akaike’s information criterion (i.e., the 
lowest number criterion using a given covariance structure represents the highest quality 
statistical model; Akaike, 1974). In Experiment 1, PCA behavior across training sessions was 
analyzed using a linear mixed model with an autoregressive (AR1) covariance structure with 
Lesion (sham, vHPC, dHPC, total HPC) as the main factor. In Experiment 2, PCA behavior 
across training sessions was analyzed using a linear mixed model (AR1 covariance structure) 
with Phenotype (GT and ST) and Lesion (sham and vHPC) as factors. For the test of temporary 
inactivation, PCA behavior was analyzed using a three-way analysis of variance (ANOVA) with 
Phenotype (GT and ST), Drug (Saline and Lidocaine), and Order (First and Second) as factors. 
For the conditioned reinforcement test, nose-poke port responses (active – inactive) were 
analyzed using a two-way ANOVA with Phenotype (GT and ST) and Lesion (sham and vHPC) 
as factors. For HPLC analysis, neurochemicals were analyzed using a two-way ANOVA with 
Lesion (sham and vHPC) and Phenotype (GT and ST) as factors. With a significant ANOVA, 
multiple comparisons were performed using Fisher’s Least Significant Difference (LSD) post 




 Excitotoxic lesions of the hippocampus (sham, n = 13; vHPC, n = 11; dHPC, n = 8; total 
HPC, n = 10) were performed prior to five daily PCA training sessions to determine whether the 
lesions affected the acquisition of PCA behavior. Figure 1 shows a schematic representation of 
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the extent of NMDA-induced lesions in the vHPC, dHPC, and total HPC. Figure 2 shows that 
there was an effect of Lesion on lever press number (F(3,38) = 2.85, p = 0.05), latency (F(3,38) = 
3.34, p = 0.029), and probability (F(3,38) = 3.31, p = 0.03) as well as magazine entry number 
(F(3,38) = 3.01, p = 0.042), and latency (F(3,38) = 3.55, p = 0.023), which were averaged over 
Sessions 4 and 5. There was no effect of Lesion on magazine entry probability (F(3,38) = 2.76, p = 
0.055). Post hoc comparisons revealed that, compared to the sham condition, vHPC lesions 
decreased lever press number (p = 0.007), latency (p = 0.009), and probability (p = 0.006) as 
well as increased magazine entry number (p = 0.019) and latency (p = 0.007). Lesions of the 
dHPC, compared to the sham condition, only increased magazine entry number (p = 0.02) and 
latency (p = 0.017). Lesions of the total HPC, compared to the sham condition, had no effect on 
any variable.  
There was an interaction of Lesion and Session on lever press number (F(16,148.84) = 2.95, 
p = 3.06 x 10
-4
), latency (F(16,143.48) = 2.99, p = 2.59 x 10
-4
), and probability (F(16,142.65) = 2.70, p = 
0.001) as well as magazine entry number (F(16,139.94) = 3.89, p = 5.0 x 10
-6
), latency (F(16,138.61) = 
4.26, p = 1.0 x 10
-6
), and probability (F(16,138.09) = 4.11, p = 2.0 x 10
-6
) (Figure 3). Post-hoc 
comparisons revealed that, compared to the sham condition, vHPC lesions decreased lever press 
number (ps < 0.01), latency (ps < 0.01), and probability (ps < 0.01) during Sessions 3-5 as well 
as increased magazine entry number (ps < 0.05), latency ps < 0.05), and probability (ps < 0.05) 
during Sessions 4-5. dHPC lesions, compared to the sham condition, increased magazine entry 
number (ps < 0.05), latency (ps < 0.05), and probability (ps < 0.05) during Sessions 3-5. Lesions 
of the total HPC, compared to the sham condition, had no effect on any variable. Figure 3 shows 
that there was an interaction of Lesion and Session on PCA index scores (F(16,142.85) = 3.02, p = 
2.33 x 10
-4
). Post-hoc comparisons revealed that only vHPC lesions, compared to the sham 
condition, decreased PCA index score (ps < 0.01) during Sessions 3-5. Lastly, there was no 
effect of Lesion on non-CS magazine entries over Sessions 1-5 (data not shown; F(3,61.75) = 0.80, 
p = 0.50). 
 
Experiment 2 
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 Before surgery, rats underwent PCA training and were classified as STs, GT, and IRs; 
however, only STs (n = 24) and GTs (n = 15) were used for further experimental testing. During 
seven daily PCA training sessions, STs and GTs differed in their lever press number (F(1,37.63) = 
29.01, p = 4.0 x 10
-6
), latency (F(1,37.17) = 37.71, p = 3.98 x 10
-7
), and probability (F(1,36.03) = 
48.61, p = 3.56 x 10
-8
) as well as their magazine entry number (F(1,47.15) = 43.17, p = 3.62 x 10
-8
), 
latency (F(1,46.28) = 54.81, p = 2.19 x 10
-9
), and probability (F(1,44.76) = 53.70, p = 3.44 x 10
-9
). STs 
and GTs differed on their PCA index scores over the seven daily PCA training sessions (Figure 
5A; F(1,40.10) = 74.51, p = 1.10 x 10
-10
), and the average PCA index scores of Sessions 6 and 7 
were used to determine PCA phenotypes. Following training, rats underwent vHPC lesions 
(Figure 4A; ST, n = 12; GT, n = 6) or sham surgeries (ST, n = 12; GT, n = 9), which included 
cannulas targeted at the vSUB (Figure 4B). Following a surgical recovery period of seven days, 
rats underwent an additional seven daily PCA training sessions to determine the effect of vHPC 
lesions on the expression of PCA behavior. In GTs, there was no effect of Lesion on lever press 
number (F(1,12.89) = 0.51, p = 0.49), latency (F(1,13.95) = 2.58, p = 0.40), and probability (F(1,13.86) = 
0.63, p = 0.44), or magazine entry number (F(1,14.24) = 1.55, p = 0.23), latency (F(1,17.49) = 0.58, p 
= 0.46), and probability (F(1,15.86) = 0.50, p = 0.49). Similarly, in STs, there was no effect of 
Lesion on lever press number (F(1,23.19) = 0.51, p = 0.48), latency (F(1,22.37) = 0.02, p = 0.88), and 
probability (F(1,20.1) = 0.71, p = 0.79) or magazine entry number (F(1,19.51) = 0.001, p = 0.97), 
latency (F(1,24.28) = 0, p = 1.0), and probability (F(1,20.9) = 0.024, p = 0.88). Furthermore, Figure 5B 
shows that there was no effect of Lesion on PCA index scores in GTs (F(1,14.29) = 0.88, p = 0.36) 
or STs (F(1,17.62) = 4.0 x 10
-5
, p = 1.0).  
Twenty-four hours after the final session of PCA training, sham controls were infused 
bilaterally in the vSUB with a 20% lidocaine solution or vehicle and tested in a counter-balanced 
manner across two PCA training sessions, which served as the test of temporary inactivation. 
Figure 4B shows a schematic representation of injection sites in the vSUB. Figure 5C shows that 
temporary inactivation of the vSUB did not affect the expression of PCA behavior in GTs (effect 
of Drug; F(1,9) = 0.02, p = 0.89) or STs (effect of Drug; F(1,13) = 0.91, p = 0.36). In addition, there 
was no effect of Order (i.e., receiving lidocaine infusion on the first test session and vehicle 
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infusion on the second test session or vice versa; F(1,22) = 0.007, p = 0.93). Rats with vHPC 
lesions underwent two PCA training sessions as well to ensure that all rats received similar 
behavioral testing procedures. Twenty-four hours later, all rats underwent a test for conditioned 
reinforcement to determine whether vHPC lesions affected the conditioned reinforcing properties 
of the lever. As expected, Figure 5D shows that STs exhibit greater conditioned reinforcement 
than GTs (i.e., higher active – inactive nose-poke port responses; effect of Phenotype; F(1, 32) = 
6.28, p = 0.018). However, vHPC lesions did not affect conditioned reinforcement in GTs (effect 
of Lesion; F(1,13) = 0.91, p = 0.36) or STs (effect of Lesion; F(1, 14) = 0.51, p = 0.49).  
Using tissue punches of the NAc taken five days after the completion of testing (Figure 
4C), HPLC analysis revealed an effect of Lesion on HVA levels (Figure 6A; F(1,30) = 7.63, p = 
0.0097) and HVA/DA (a marker of DA release and metabolism; Figure 6B; F(1,30) = 6.90, p = 
0.013). Post hoc comparisons showed that lesions decreased HVA levels in STs (p = 0.0014), but 
not GTs (p = 0.51), and decreased HVA/DA in STs (p = 0.011), but not GTs (p = 0.26). In 
addition, there was an effect of Lesion on NE levels across phenotypes (Figure 6C; F(1,30) = 4.21, 
p = 0.049). There was no effect of Lesion (data not shown) on levels of DA (F(1,30) = 0.008, p = 
0.93), DOPAC (F(1,30) = 0.004, p = 0.95), 3-MT (F(1,30) = 0.97, p = 0.33), 5-HT (F(1,30) = 1.37, p = 
0.25), or 5-HIAA (F(1,30) = 0.22, p = 0.64).  
 
Discussion  
 The present study investigated the role of the HPC in the acquisition and expression of 
PCA behavior. In Experiment 1, we found that vHPC lesions decreased sign-tracking behavior 
and increased goal-tracking behavior during the acquisition of PCA training. Moreover, dHPC 
lesions also increased goal-tracking behavior, while total HPC lesions had no effect. 
Consequently, only the vHPC was further investigated in Experiment 2. During this experiment, 
we demonstrated that neither vHPC lesions nor temporary inactivation of the vSUB, the main 
output structure of the vHPC, affected the expression of PCA behavior. Post-conditioning lesions 
of the vHPC also did not affect conditioned reinforcement. Finally, lesions of the vHPC 
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decreased NE across both phenotypes, and decreased HVA and HVA/DA (a marker of DA 
release and metabolism) in STs, but not GTs.    
In agreement with our hypothesis, vHPC lesions decreased the acquisition of sign-
tracking (and also increased the acquisition of goal-tracking) behavior in rats. vHPC lesions may 
have decreased sign-tracking behavior by attenuating activity of dopaminergic cell bodies in the 
VTA (Floresco et al., 2001) and/or VTA terminals in the NAc or their terminals in the NAc 
(Blaha et al., 1997). Alternatively, the loss of glutamatergic input from the vHPC to medium 
spiny neurons in the NAc may have also decreased sign-tracking behavior by disrupting gating 
and outflow of NAc signals (French and Totterdell, 2002).  
Interestingly, total HPC lesions did not have a similar effect as vHPC lesions, even 
though the region is included in the total HPC lesion. Previously, it has been reported that 
neonatal vHPC-induced amphetamine hyperlocomotion is abolished if the lesion encompasses 
both the vHPC and dHPC, similar to our total HPC lesion (Swerdlow et al., 2001). The authors 
suggested that the larger lesions may diminish a complex inhibitory control from the vHPC to 
dHPC that is critical for vHPC-induced behavioral alterations. A similar phenomenon may have 
occurred with our total HPC lesions, although future experiments, such as disconnection 
procedures, would need to be performed to investigate this question. 
Unexpectedly, dHPC lesions also increased the acquisition of goal-tracking behavior. The 
dHPC has a role in the predictive value of a CS during Pavlovian conditioning (Munera et al., 
2001) and cue-reward associations (Jacquet et al., 2013); therefore, it may seem counterintuitive 
that dHPC lesions increased goal-tracking behavior. It is possible, however, that neural activity 
in the dHPC competes with other brain regions during the acquisition of goal-tracking behavior, 
and dHPC lesions release these regions, facilitating goal-tracking behavior. For example, in an 
appetitive conditioned cue preference procedure, it has been suggested that competition between 
the HPC and lateral amygdala balances learning strategies with the lateral amygdala facilitating 
approach behavior to the site of food delivery in the absence of hippocampal activity (Chai and 
White, 2004; Gaskin and White, 2006).  
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In addition, our data seem to be at odds with previous reports that total HPC lesions 
increase sign-tracking behavior (Ito et al., 2005). It is possible that this incongruence arises from 
experimental differences in CS-US proximity (Christie, 1996), CS modality (Beckmann and 
Chow, 2015), or even rat strain differences in lesion-induced behavioral alterations (Lipska and 
Weinberger, 1995; Wood et al., 2001). However, the most likely explanation is that the PCA 
procedure employed by Ito et al. involves discrimination between a CS+ and CS- that are 
identical except for their physical location on the left or right of the wall. Rats in their study were 
required to be at the opposite side of the testing chamber before the start of each trial, which 
ensured that the CS+ was always on the same side of their body. Therefore, to discriminate 
between the two stimuli, the rats could either identify the actual location of the CS within the 
chamber, in a hippocampal-dependent manner, or simply identify whether the CS was on the left 
or right of their visual field. The latter strategy is both more efficient and hippocampal-
independent, so elimination of competition from slower hippocampal-dependent processes can 
actually facilitate performance of such a task (Sanderson et al., 2012). The PCA procedure in the 
present study did not involve discrimination and would therefore not be expected to improve in 
this manner with hippocampal damage. 
 Following PCA training, vHPC lesions did not affect the expression of sign- or goal-
tracking behaviors. In addition, vHPC lesions did not affect the conditioned reinforcing 
properties of the lever, although, consistent with previous findings, STs displayed higher 
conditioned reinforcement than GTs (Robinson and Flagel, 2009). Similarly, temporary 
inactivation of the vSUB did not affect the expression of either sign- or goal-tracking behaviors. 
Previously, it has been demonstrated that sign-tracking behavior becomes DA-independent after 
sufficient training (Clark et al., 2013; Darvas et al., 2014). Therefore, if the vHPC facilitates DA 
release in the NAc during PCA behavior, it may only be required during acquisition, and not 
expression following extended training, during which dopaminergic activity is no longer required 
for the maintenance of conditioned responding. 
Our neurochemical results are in agreement with previous findings that HPC lesions 
decrease DA metabolites and NE in the NAc (Springer and Isaacson, 1982). Interestingly, we 
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demonstrated that vHPC lesions attenuate HVA and HVA/DA in STs but not GTs. Individual 
differences in the functional connectivity between the HPC, NAc, and ventral tegmental area 
(VTA) have been demonstrated in humans (Kahn and Shohamy, 2013), and differential 
connectivity within these regions may have resulted in our observed differences in HVA and 
HVA/DA following vHPC lesions. In the current experiment, we were unable to determine 
through what pathways the vHPC influences dopaminergic activity in the NAc; however, it is 
known that the vHPC modulates both dopaminergic cell bodies of the VTA, which project to the 
NAc (Floresco et al., 2001), and VTA terminals in the NAc (Blaha et al., 1997). With regard to 
NE, the NAc receives primary noradrenergic input from the A1 cell group of the nucleus tractus 
solitarius (NTS) in the ventral medulla (Delfs et al., 1998). Although the vHPC does not directly 
innervate the NTS, it can regulate NTS activity through an indirect circuit involving the 
infralimbic cortex, which projects directly to the NTS (Fisk and Wyss, 2000; Ruit and Neafsey, 
1990). Transection of the ventral noradrenergic bundle, which contains noradrenergic projections 
from the NTS, decreases DA turnover in the NAc (O'Donohue et al., 1979). Therefore, the 
decreases in NE levels and DA turnover may be interconnected, especially given the fact that 
individual differences have been identified in the ability of noradrenergic compounds to 
modulate DA in the NAc (Tuinstra and Cools, 2000). Alternatively, it is possible that tissue 
punches included adjacent NE-rich regions, such as the ventral pallidum and bed nucleus of the 
stria terminalis, which are contiguous with the NAc (Berridge et al., 1997), receive noradrenergic 
innervation from the locus coeruleus (Jones and Yang, 1985), and could have contributed to 
observed differences in NE levels. 
In summary, preconditioning lesions of the vHPC, but not dHPC or total HPC, decreased 
sign-tracking behavior while increasing goal-tracking behavior during the acquisition of PCA 
behavior. Moreover, post-conditioning lesions of the vHPC did not affect the expression of PCA 
behavior or conditioned reinforcement. In addition, vHPC lesion-induced alterations in DA 
turnover and NE levels in the NAc may underlie the observed changes in PCA behavior. These 
results demonstrate that the vHPC is critical for the acquisition, but not expression, of sign-
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tracking behavior and adds to a growing body of literature indicating that the vHPC modulates 
motivated behavior and vulnerability to addiction (Jasinska et al., 2014; Robbins et al., 2008).  
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Figures and Legends 
Figure 1. Schematic representation of NMDA lesions of the (A) dorsal, (B) ventral, and (C) total 
hippocampus. Cresyl violet-stained sections were visualized underneath a light microscope, and 
the largest (dark gray) and smallest (light gray) lesions were identified. Coronal sections are 
presented from 1.88 to 6.30 mm posterior to bregma (adapted from Paxinos and Watson, 2007).  
 
Figure 2. Before Pavlovian conditioned approach training, surgeries were performed to lesion the 
ventral, dorsal, or total hippocampus. After surgical recovery, rats underwent five daily sessions 
of PCA training, and the number, latency, and probability of lever presses and magazine entries 
were averaged over Sessions 4 and 5. Data are presented as mean + S.E.M. * - p < 0.05, ** - p < 
0.01. 
 
Figure 3. Pavlovian conditioned approach (PCA) index scores of rats that underwent ventral, 
dorsal, or total hippocampal lesions before the acquisition of PCA training. Data are presented as 
mean ± S.E.M. ** < 0.01, compared to the sham group. 
 
Figure 4. Schematic representation (adapted from Paxinos and Watson, 2007) of (A) NMDA-
induced lesions of the ventral hippocampus (coronal sections presented from 4.52 to 6.30 mm 
posterior to bregma), (B) cannulas bilaterally targeted at the ventral subiculum (coronal sections 
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presented from 5.30 to 6.30 mm posterior to bregma), and (C) tissue punches taken from the 
nucleus accumbens (coronal section presented at 1.20 anterior to bregma). For ventral 
hippocampal lesions, the largest (dark gray) and smallest (light gray) lesions were identified. For 
cannula placements, black circles represent the location of the infusion cannula tip. For tissue 
punches, the location of the 2-mm tissue punch is shaded (light gray). 
 
Figure 5. (A) Rats underwent seven daily sessions of Pavlovian conditioned approach (PCA) 
training, and the average PCA index scores of Sessions 6 and 7 were used to phenotype STs and 
GTs. (B) Af er performing surgeries to lesion the ventral hippocampus (Lesion) or implant guide 
cannulas targeted at the ventral subiculum (Sham), rats underwent another seven daily sessions 
of PCA training. (C) Next, sham rats were infused with either lidocaine (20% solution) or saline 
in a counter-balanced manner immediately before two additional PCA training sessions, which 
served as a temporary inactivation test. (D) Finally, all rats underwent a conditioned 
reinforcement test during which active but not inactive nose-poke (NP) responses resulted in 2-s 
presentations of the lever. Data are presented as mean ± S.E.M. * - p < 0.05. 
 
Figure 6. Five days following the last test session (conditioned reinforcement), tissue punches of 
the nucleus accumbens were taken to measure levels of monoamines and their metabolites using 
HPLC. Significant differences between lesion (ventral hippocampus) and sham rats were 
observed with (A) homovanillic acid (HVA), (B) the ratio of HVA to dopamine (DA), and (C) 
norepinephrine (NE). Data are presented as mean + S.E.M. * - p < 0.05, ** - p < 0.01.  
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Figure 1. Schematic representation of NMDA lesions of the (A) dorsal, (B) ventral, and (C) total 
hippocampus. Cresyl violet-stained sections were visualized underneath a light microscope, and the largest 
(dark gray) and smallest (light gray) lesions were identified. Coronal sections are presented from 1.88 to 
6.30 mm posterior to bregma (adapted from Paxinos and Watson, 2007).  
Figure 1  
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Figure 2. Before Pavlovian conditioned approach training, surgeries were performed to lesion the ventral, 
dorsal, or total hippocampus. After surgical recovery, rats underwent five daily sessions of PCA training, and 
the number, latency, and probability of lever presses and magazine entries were averaged over Sessions 4 
and 5. Data are presented as mean + S.E.M. * - p < 0.05, ** - p < 0.01.  
Figure 2  
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Figure 3. Pavlovian conditioned approach (PCA) index scores of rats that underwent ventral, dorsal, or total 
hippocampal lesions before the acquisition of PCA training. Data are presented as mean ± S.E.M. ** < 0.01, 
compared to the sham group.  
Figure 3  
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Figure 4. Schematic representation (adapted from Paxinos and Watson, 2007) of (A) NMDA-induced lesions 
of the ventral hippocampus (coronal sections presented from 4.52 to 6.30 mm posterior to bregma), (B) 
cannulas bilaterally targeted at the ventral subiculum (coronal sections presented from 5.30 to 6.30 mm 
posterior to bregma), and (C) tissue punches taken from the nucleus accumbens (coronal section presented 
at 1.20 anterior to bregma). For ventral hippocampal lesions, the largest (dark gray) and smallest (light 
gray) lesions were identified. For cannula placements, black circles represent the location of the infusion 
cannula tip. For tissue punches, the location of the 2-mm tissue punch is shaded (light gray).  
Figure 4  
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Figure 5. (A) Rats underwent seven daily sessions of Pavlovian conditioned approach (PCA) training, and the 
average PCA index scores of Sessions 6 and 7 were used to phenotype STs and GTs. (B) After performing 
surgeries to lesion the ventral hippocampus (Lesion) or implant guide cannulas targeted at the ventral 
subiculum (Sham), rats underwent another seven daily sessions of PCA training. (C) Next, sham rats were 
infused with either lidocaine (20% solution) or saline in a counter-balanced manner immediately before two 
additional PCA training sessions, which served as a temporary inactivation test. (D) Finally, all rats 
underwent a conditioned reinforcement test during which active but not inactive nose-poke (NP) responses 
result d in 2-s presentations of the lever. Data are presented as mean ± S.E.M. * - p < 0.05.  
Figure 5  
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Figure 6. Five days following the last test session (conditioned reinforcement), tissue punches of the nucleus 
accumbens were taken to measure levels of monoamines and their metabolites using HPLC. Significant 
differences between lesion (ventral hippocampus) and sham rats were observed with (A) homovanillic acid 
(HVA), (B) the ratio of HVA to dopamine (DA), and (C) norepinephrine (NE). Data are presented as mean + 
S.E.M. * - p < 0.05, ** - p < 0.01.  
Figure 6  
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